Coral Drugs Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 1993.
1993 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Coral Drugs Private Limited

Coral Drugs Private Limited, a active private limited company, was established on 22 December 1993 in New Delhi, Delhi, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U74899DL1993PTC056582. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹9.00 M and a paid-up capital of ₹4.24 M.

Formerly known as Coral Tex Knit Private Limited. It upholds a compliant status. Its leadership includes Pawan Kumar Agarwal (Director), Ravi Pratap Srivastava (Whole-Time Director), Meena Bhuwania (Whole-Time Director). Past directors included Shyam Sunder Sharma, Rakesh Kumar Nigam, Pawan Kumar Agarwal. It holds ₹11.35 Cr open charges and ₹38.05 Cr settled loans. Its latest AGM occurred on 04 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1001 Akash Deep Building, 26-A, Barakhamba Road, New Delhi, Delhi, 110001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74899DL1993PTC056582

  • Registration Number

    056582

  • Incorporation Date

    22 December 1993

  • Authorized Capital

    ₹9.00 M

  • Paid-Up Capital

    ₹4.24 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 9.00 M
  • Paid Up Capital ₹ 4.24 M
  • Company Age 32 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 11.35 Cr
  • Satisfied Charges ₹ 38.05 Cr
  • Revenue Growth **** 22.16%
  • Profit Growth **** 23.00%
  • Ebitda **** 26.27%
  • Net Worth 14.12%
  • Total Assets **** 11.60%
Company report

Coral Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Coral Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Coral Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Pawan Kumar Agarwal Director 15 Jan 2024 Current
Ravi Pratap Srivastava Whole-Time Director 20 Sep 2023 Current
Meena Bhuwania Whole-Time Director 01 Dec 1998 Current
Binay Kumar Bhuwania Whole-Time Director 22 Dec 1993 Current
Rohit Bhuwania Managing Director 07 Nov 2002 Current
Neeraj Ramesh Lal Mankani Additional Director 20 Jan 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 22 Oct 2010 Past
Pramod Abcsdd Whole-Time Director 18 Apr 2009 Past
Pramod Abcsdd Additional Director 03 Sep 2024 Past
Pramod Abcsdd Additional Director 20 Sep 2023 Past
Pramod Abcsdd Whole-Time Director 31 Mar 2016 Past
Pramod Abcsdd Director 27 May 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Coral Drugs.

Coral Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.16% increase. The company also saw a substantial improvement in profitability, with a 23% increase in profit. The company's net worth Soared by an impressive increase of 14.12%.

Coral Drugs revenue growth over time
Coral Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 22.16%
*******
*******
*******
*******
Revenue from Operations
*******
 23.53%
*******
*******
*******
*******
Total Assets
*******
 11.60%
*******
*******
*******
*******
Profit or Loss
*******
 23.00%
*******
*******
*******
*******
Net Worth
*******
 14.12%
*******
*******
*******
*******
EBITDA
*******
 26.27%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Coral Drugs?

In 2023, Coral Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹113,512,685.00

Satisfied Charges

₹380,519,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 7.00 Cr
  • Bank Of India : 3.23 Cr
  • Pnb Housing Finance Limited : 0.60 Cr
  • Others : 0.52 Cr
Latest Charge Details
Date Lender Amount Status
25 Feb 2021 Hdfc Bank Limited ₹7.00 Cr Open
29 Nov 2017 Others ₹5.21 M Open
01 Sep 2017 Bank Of India ₹3.23 Cr Open
15 Mar 2013 Pnb Housing Finance Limited ₹6.00 M Open
28 Feb 2015 Bank Of India ₹3.40 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Coral Drugs?

Unlock and access historical data on people associated with Coral Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Coral Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Coral Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Coral Drugs
Recent Activity within the Organization
  • Director Appointment

    The activity Neeraj Ramesh Lal Mankani was appointed as a Additional Director was appointed as a Additional Director on 20 Jan 2025 & has been associated with this company since 1 year 1 month . was completed.

  • Annual General Meeting

    Coral Drugs Private Limited last Annual general meeting of members was held on 04 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Coral Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Progress on Pawan Kumar Agarwal was appointed as a Director was appointed as a Director on 15 Jan 2024 & has been associated with this company since 2 years 1 month . was documented.

  • Charges

    Progress on A charge with Bank Of India of Rs. 32.30 M registered on 01 Sep 2017 with Charge ID 100124673 was modified on 04 Jan 2024. was documented.

  • Director Appointment

    Ravi Pratap Srivastava was appointed as a Whole-time director was appointed as a Whole-time director on 20 Sep 2023 & has been associated with this company since 2 years 5 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Coral Drugs Private Limited?

The CIN of Coral Drugs Private Limited is U74899DL1993PTC056582.

Where is Coral Drugs Private Limited headquartered?

Coral Drugs Private Limited is headquartered at 1001 Akash Deep Building, 26-A, Barakhamba Road, New Delhi, Delhi, 110001.

When was Coral Drugs Private Limited incorporated?

Coral Drugs Private Limited was incorporated on 22 December 1993.

Who are the current directors of Coral Drugs Private Limited?

The current directors of Coral Drugs Private Limited are

What is the primary industry of Coral Drugs Private Limited?

The primary industry of Coral Drugs Private Limited is Manufacturing.

Is Coral Drugs Private Limited a listed company?

Coral Drugs Private Limited is unlisted.

What is the capital structure of Coral Drugs Private Limited?

The authorized capital of Coral Drugs Private Limited is ₹9.00 M, and the paid-up capital is ₹4.24 M.

What is the compliance status of Coral Drugs Private Limited?

The compliance status of Coral Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available